DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar FinanceGuy58 (34.59) Submitted: 9/17/2009 8:05:17 PM : Outperform Start Price: $2.64 DRRX Score: -88.31

A small company that develops proprietary drug delivery technologies for their drug development partners. Remember Alza? These guys are a mini-Alza (and they have several ex-Alza guys on the team.) The upside won't be as strong as owning the drug company directly, but this should be a nice portfolio of royalties from several different drug products. I've traded this between this level and $7 a couple times over the years.

Featured Broker Partners


Advertisement